[AI Medical Technology Company Triomics Completes $22 Million Series B Financing, Led by Battery Ventures] BlockBeats News, May 28, according to TechCrunch, Triomics is a startup developing an AI-driven platform aimed at helping oncologists and administrators automate data-intensive tasks, such as clinical trial matching and appointment preparation. The company has completed a $22 million Series B financing round. This round was led by Battery Ventures, with participation from existing investors such as Nexus Venture Partners, Lightspeed, and Y Combinator. Founded in 2021, the startup previously completed a $15 million Series A financing round in mid-2024. Initially, Triomics focused on assisting doctors in screening the most suitable clinical trials for patients. With the advancement of large language model (LLM) capabilities, the company has gradually expanded its platform's functionalities. Over the past few years, Triomics has added features like verifiable patient summaries to its platform, enabling key information to be presented directly within tools already used by clinicians, eliminating the need for frequent switching between different applications. Click the link below to access the original article and join the Beating · Feishu AI News Channel for 24/7 global AI news and updates. [Original Link]